Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Orphanet Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol COL4A1 contributors: shn/mct - updated : 06-11-2017
HGNC name collagen, type IV, alpha 1
HGNC id 2202
ASSOCIATED DISORDERS
corresponding disease(s) PRCF , HANAC , COSS , WLKWS9 , BSVD , COL4A1D
Other morbid association(s)
TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
constitutional germinal mutation      
in cerebral hemorrhage and porencephaly
constitutional germinal mutation      
in anophthalmia/microphthalmia (A/M) (PMID;
constitutional germinal mutation      
in non-syndromic, autosomal dominant congenital cataract
Susceptibility to perinatal cerebral haemorrhage and porencephaly
Variant & Polymorphism
Candidate gene
Marker
Therapy target
SystemTypeDisorderPubmed
neurosensorial  
endothelial-specific inhibitory actions of recombinant alpha1(IV)NC1 (COL4A1) may be of benefit in the treatment of a variety of eye diseases with a neovascular component
cardiovascular  
a mechanism-based therapy promoting protein folding might prevent intracerebral hemorrhage (ICH) in patients with COL4A1 and COL4A2 mutations
ANIMAL & CELL MODELS
  • Col4a1 mutant mouse develops porencephaly secondary to focal disruptions of vascular basement membranes and dies with cerebral hemorrhage within a day of birth (Gould et al, 2005)
  • Col4a1 mutant mice develop progressive skeletal myopathy
  • HANAC mutant mice presented with a muscular functional impairment and increased serum creatine kinase levels reflecting altered muscle fiber sarcolemma
  • heterozygous Col4a1 mutant mice have ocular dysgenesis, neuronal localization defects, and myopathy characteristic of MEB/WWS